Actemra 200mg, a treatment known scientifically as tocilizumab, is a a potent therapeutical agent primarily used for the control of rheumatoid arthritis. This effective compound operates by inhibiting the activity of interleukin-6 (IL-6), a regulatory protein crucial in the inflammatory process. Additionally, Actemra exhibits effectiveness in the